vs

Side-by-side financial comparison of EnerSys (ENS) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $919.1M, roughly 1.6× EnerSys). EnerSys runs the higher net margin — 9.8% vs 4.4%, a 5.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 1.4%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $171.3M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 0.5%).

EnerSys is a stored energy systems and technology provider for industrial applications. The company manufactures reserve-power and motive-power batteries, battery chargers, power equipment, battery accessories and outdoor equipment enclosures.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

ENS vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.6× larger
ONC
$1.5B
$919.1M
ENS
Growing faster (revenue YoY)
ONC
ONC
+31.4% gap
ONC
32.8%
1.4%
ENS
Higher net margin
ENS
ENS
5.4% more per $
ENS
9.8%
4.4%
ONC
More free cash flow
ONC
ONC
$208.6M more FCF
ONC
$379.8M
$171.3M
ENS
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
0.5%
ENS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ENS
ENS
ONC
ONC
Revenue
$919.1M
$1.5B
Net Profit
$90.4M
$66.5M
Gross Margin
30.1%
90.5%
Operating Margin
13.5%
12.4%
Net Margin
9.8%
4.4%
Revenue YoY
1.4%
32.8%
Net Profit YoY
-21.3%
143.8%
EPS (diluted)
$2.40
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENS
ENS
ONC
ONC
Q4 25
$919.1M
$1.5B
Q3 25
$951.3M
$1.4B
Q2 25
$893.0M
$1.3B
Q1 25
$974.8M
$1.1B
Q4 24
$906.2M
$1.1B
Q3 24
$883.7M
$1.0B
Q2 24
$852.9M
$929.2M
Q1 24
$910.7M
$751.7M
Net Profit
ENS
ENS
ONC
ONC
Q4 25
$90.4M
$66.5M
Q3 25
$68.4M
$124.8M
Q2 25
$57.5M
$94.3M
Q1 25
$96.5M
$1.3M
Q4 24
$114.8M
$-151.9M
Q3 24
$82.3M
$-121.3M
Q2 24
$70.1M
$-120.4M
Q1 24
$60.9M
$-251.2M
Gross Margin
ENS
ENS
ONC
ONC
Q4 25
30.1%
90.5%
Q3 25
29.1%
86.1%
Q2 25
28.4%
87.5%
Q1 25
31.2%
85.2%
Q4 24
32.9%
85.8%
Q3 24
28.5%
83.0%
Q2 24
27.9%
85.1%
Q1 24
27.9%
83.4%
Operating Margin
ENS
ENS
ONC
ONC
Q4 25
13.5%
12.4%
Q3 25
9.7%
11.5%
Q2 25
9.7%
6.7%
Q1 25
13.5%
1.0%
Q4 24
15.7%
-7.0%
Q3 24
11.2%
-12.0%
Q2 24
10.7%
-11.5%
Q1 24
8.9%
-34.8%
Net Margin
ENS
ENS
ONC
ONC
Q4 25
9.8%
4.4%
Q3 25
7.2%
8.8%
Q2 25
6.4%
7.2%
Q1 25
9.9%
0.1%
Q4 24
12.7%
-13.5%
Q3 24
9.3%
-12.1%
Q2 24
8.2%
-13.0%
Q1 24
6.7%
-33.4%
EPS (diluted)
ENS
ENS
ONC
ONC
Q4 25
$2.40
$0.05
Q3 25
$1.80
$0.08
Q2 25
$1.46
$0.06
Q1 25
$2.39
$0.00
Q4 24
$2.88
$-0.10
Q3 24
$2.01
$-0.09
Q2 24
$1.71
$-0.09
Q1 24
$1.48
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENS
ENS
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$450.1M
$4.5B
Total DebtLower is stronger
$836.4M
Stockholders' EquityBook value
$1.9B
$4.4B
Total Assets
$4.0B
$8.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENS
ENS
ONC
ONC
Q4 25
$450.1M
$4.5B
Q3 25
$388.6M
$4.0B
Q2 25
$346.7M
$2.8B
Q1 25
$343.1M
$2.5B
Q4 24
$463.2M
$2.6B
Q3 24
$407.9M
$2.7B
Q2 24
$344.1M
$2.6B
Q1 24
$333.3M
$2.8B
Total Debt
ENS
ENS
ONC
ONC
Q4 25
$836.4M
Q3 25
Q2 25
Q1 25
$1.1B
Q4 24
Q3 24
Q2 24
Q1 24
$802.0M
Stockholders' Equity
ENS
ENS
ONC
ONC
Q4 25
$1.9B
$4.4B
Q3 25
$1.9B
$4.1B
Q2 25
$1.9B
$3.8B
Q1 25
$1.9B
$3.5B
Q4 24
$1.8B
$3.3B
Q3 24
$1.8B
$3.4B
Q2 24
$1.8B
$3.4B
Q1 24
$1.8B
$3.4B
Total Assets
ENS
ENS
ONC
ONC
Q4 25
$4.0B
$8.2B
Q3 25
$4.1B
$7.6B
Q2 25
$4.1B
$6.3B
Q1 25
$4.0B
$5.8B
Q4 24
$4.0B
$5.9B
Q3 24
$4.0B
$5.8B
Q2 24
$3.6B
$5.7B
Q1 24
$3.5B
$5.7B
Debt / Equity
ENS
ENS
ONC
ONC
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
0.57×
Q4 24
Q3 24
Q2 24
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENS
ENS
ONC
ONC
Operating Cash FlowLast quarter
$184.6M
$417.3M
Free Cash FlowOCF − Capex
$171.3M
$379.8M
FCF MarginFCF / Revenue
18.6%
25.4%
Capex IntensityCapex / Revenue
1.4%
2.5%
Cash ConversionOCF / Net Profit
2.04×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$441.3M
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENS
ENS
ONC
ONC
Q4 25
$184.6M
$417.3M
Q3 25
$218.0M
$402.6M
Q2 25
$968.0K
$263.6M
Q1 25
$135.2M
$44.1M
Q4 24
$81.1M
$75.2M
Q3 24
$33.6M
$188.4M
Q2 24
$10.4M
$-95.6M
Q1 24
$-308.6M
Free Cash Flow
ENS
ENS
ONC
ONC
Q4 25
$171.3M
$379.8M
Q3 25
$197.1M
$354.5M
Q2 25
$-32.1M
$219.8M
Q1 25
$104.9M
$-12.3M
Q4 24
$56.8M
$-17.3M
Q3 24
$3.3M
$54.7M
Q2 24
$-25.7M
$-205.5M
Q1 24
$-465.1M
FCF Margin
ENS
ENS
ONC
ONC
Q4 25
18.6%
25.4%
Q3 25
20.7%
25.1%
Q2 25
-3.6%
16.7%
Q1 25
10.8%
-1.1%
Q4 24
6.3%
-1.5%
Q3 24
0.4%
5.5%
Q2 24
-3.0%
-22.1%
Q1 24
-61.9%
Capex Intensity
ENS
ENS
ONC
ONC
Q4 25
1.4%
2.5%
Q3 25
2.2%
3.4%
Q2 25
3.7%
3.3%
Q1 25
3.1%
5.0%
Q4 24
2.7%
8.2%
Q3 24
3.4%
13.3%
Q2 24
4.2%
11.8%
Q1 24
20.8%
Cash Conversion
ENS
ENS
ONC
ONC
Q4 25
2.04×
6.28×
Q3 25
3.19×
3.22×
Q2 25
0.02×
2.79×
Q1 25
1.40×
34.71×
Q4 24
0.71×
Q3 24
0.41×
Q2 24
0.15×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENS
ENS

Energy Systems$399.5M43%
Motive Power$352.0M38%
Services$92.6M10%
Transferred Over Time$38.2M4%
Other$36.8M4%

ONC
ONC

Segment breakdown not available.

Related Comparisons